Ozempic Lawsuit in Florida (GLP-1 Claims)

What Florida residents should know

Florida residents with GLP-1 injury claims are generally not limited to Florida state court. Most filed cases are transferred into the federal multidistrict litigation, MDL-3094, before Judge Karen S. Marston in the Eastern District of Pennsylvania, which held 3,763 pending cases as of June 1, 2026.

Florida law still matters: the state's filing deadline, damages rules, and procedural law can shape an individual claim even when the case is litigated in the MDL.

Florida coverage legislation and the Ozempic litigation

Florida residents' federal GLP-1 injury cases are transferred into MDL-3094 in the U.S. District Court for the Eastern District of Pennsylvania for coordinated proceedings. In the 2026 session, Florida lawmakers considered Senate Bill 1070 and House Bill 977, which would have required the State Group Insurance Program (the state-employee health plan) to cover obesity treatment, including GLP-1 medications; both bills died in committee on March 13, 2026.

Sources: Florida Senate — SB 1070 (2026), State Group Insurance Program Coverage for Obesity Treatment; Florida Legislature — HB 977 (2026), Benefits for Obesity under the State Group Health Insurance Plan.

Possible eligibility factors

• Documented use of a GLP-1 medication (prescription and pharmacy records from Florida providers).
• A diagnosis such as gastroparesis, ileus, or bowel obstruction — commonly supported by a gastric emptying study, endoscopy, imaging, or hospitalization records.
• Injury timing consistent with medication use.
• Filing within the deadline that applies to the claim under Florida law.

How Florida claims proceed

Most Florida GLP-1 cases are filed in or transferred to MDL-3094 in the Eastern District of Pennsylvania for coordinated proceedings. The court has scheduled Rule 702 expert-admissibility hearings for September 10–18, 2026 (Case Management Order No. 32); bellwether trial dates have not yet been set. Florida generally provides four years for an injury claim founded on the design, manufacture, distribution, or sale of personal property (Fla. Stat. § 95.11(3)(d)), but accrual, repose, and other claim-specific rules can affect the deadline.

What records support Ozempic claims in Florida?

• Prescription, pharmacy, insurance, or provider records showing Ozempic or another GLP-1 medication and dates of use.
• Emergency room, hospital, gastroenterology, imaging, gastric-emptying, surgery, or follow-up records for the alleged injury.
• Records showing diagnosis timing for gastroparesis, bowel obstruction, ileus, aspiration, or related complications.
• Medication history, dose changes, side-effect reports, provider messages, and documents that help connect use and symptoms.

What exposure and legal context matter in Florida?

Florida residents may have been prescribed Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, Zepbound, or Trulicity through endocrinologists, primary care practices, weight-management clinics, telehealth services, or hospital systems across the state.

Where are Florida Ozempic cases handled?

Living in Florida does not necessarily mean the case will be filed only in Florida. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.

Federal courts in Florida

• Northern District of Florida
• Middle District of Florida
• Southern District of Florida

What is the filing deadline for Ozempic lawsuits in Florida?

For a Florida resident researching Ozempic claims, the starting point is usually Florida's general personal injury period: 4 years under Fla. Stat. § 95.11(3)(d). That is only a starting point, not a final legal deadline for every person.

The real filing deadline can depend on diagnosis date, when the injury and possible cause were discovered, exposure location, wrongful-death issues, prior claim paperwork, and whether the case is filed directly, transferred to an MDL, or handled through another process.

Discovery-rule note: Florida applies a four-year period to injury actions founded on the design, manufacture, distribution, or sale of personal property. Florida's 2023 tort reform (HB 837) cut the general negligence period to two years (§ 95.11(4)(a)) but did not change the product-liability period at § 95.11(3)(d). Latent-injury accrual rules can apply.

How long do Florida residents have to file?

Florida's personal injury statute of limitations applicable to product liability claims is 4 years (Fla. Stat. § 95.11(3)(d)). Accrual timing, tolling, and repose periods can still change the real deadline in an individual case.

• Filing period: 4 years — Fla. Stat. § 95.11(3)(d).
• Discovery rule: Florida applies a four-year period to injury actions founded on the design, manufacture, distribution, or sale of personal property. Florida's 2023 tort reform (HB 837) cut the general negligence period to two years (§ 95.11(4)(a)) but did not change the product-liability period at § 95.11(3)(d). Latent-injury accrual rules can apply.
• Statute of repose: Florida product liability claims can be subject to a 12-year repose period for certain products (§ 95.031).

Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.

What should Florida residents ask a lawyer?

• Which GLP-1 medication and injury records do you need for an initial review?
• Do I need a gastric-emptying study, hospitalization record, imaging report, or specialist diagnosis?
• How do the Rule 702 schedule and lack of bellwether trial dates affect current claim review?
• How do state filing deadlines apply to my medication and symptom timeline?
• Would my claim be handled locally, nationally, or through the MDL?
• Are there upfront costs?